San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has renamed itself Mast Therapeutics. The firm also said it has swapped its ticker symbol to MSTX on the NYSE market. The firm, which is developing treatments for sickle cell disease and acute limb ischemia, did not give a reason for the name change.
Top NewsMonday, March 11, 2013
ADVENTRX Becomes Mast Therapeutics